低分子肝素治疗胎儿生长受限56例疗效观察 |
| |
引用本文: | 陈素青,刘宏改. 低分子肝素治疗胎儿生长受限56例疗效观察[J]. 陕西医学杂志, 2010, 39(5): 556-558 |
| |
作者姓名: | 陈素青 刘宏改 |
| |
作者单位: | 河南省洛阳市中心医院妇产科,洛阳,471009 |
| |
摘 要: | 目的:探讨低分子肝素治疗胎儿生长受限(FGR)的临床疗效。方法:对56例胎儿生长受限者采用低分子肝素治疗,并测定治疗前后的宫高、腹围、胎儿双顶径以及出生后的新生儿体重及胎盘重量,与对照组33例进行对比分析。结果:治疗组上述各项指标均高于对照组(P<0.05);两组低体重儿发生率及早产率存在显著性差异(P<0.05)。结论:低分子肝素能有效的治疗FGR,改善胎儿宫内生长发育状况。
|
关 键 词: | 胎儿生长迟缓/诊断 胎儿生长迟缓/药物疗法 肝素,低分子量/治疗应用 |
The clinnical observation of the treatment of fetal growth restriction for 56 cases with low molecular weight heparin |
| |
Affiliation: | Department of The Obstetrics , Gynecology,Luoyang Central Hospital ofHenan Province(Luoyang 471009)Chen Suqing Liu Honggai |
| |
Abstract: | Objective:To discuss the clinical effect of low molecular weight heparin on fetal growth restriction(FGR).Methods:Low molecular weight heparin was used in 56 cases with FGR as the study group.Compared the difference in height of fundus of uterus,abdominal circumference of fetus,biparietal diameter of fetus,birth weight of neonates and placenta weight between the study group and the control group(33 cases with FGR)before and after the treatment.Results:All the above indexes listed of the study group were obv... |
| |
Keywords: | Fetal growth retardation/diagnosis Fetal growth retardation/drug therapy Heparin low-molecular-weight/therapeutic use |
本文献已被 CNKI 维普 万方数据 等数据库收录! |
|